Mach5 Therapeutics
Mach5 Therapeutics is a startup headquartered in Atlanta, United States, founded in 2023. It has raised at least $21.9m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Mach5 Therapeutics has raised at least $21.9m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Mach5 Therapeutics sits inside the Atlanta R&D ecosystem in the Global R&D Labs Directory.
Other startups in Atlanta
- ABLi Therapeutics
- AlmataBio
- Amplifier
- Andson Biotech
- Dink Technologies
- Doculy
- Emrgy
- Falcomm
- Gridline Holdings
- HatchWorks Holdings
- Huxley Medical
Related
- Innovation profile of Atlanta
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Mach5 Therapeutics do?
Mach5 Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Mach5 Therapeutics raised?
At least $21.9m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Mach5 Therapeutics based?
Mach5 Therapeutics is headquartered in Atlanta, United States.
When was Mach5 Therapeutics founded?
Mach5 Therapeutics was founded in 2023.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.